24小时热门版块排行榜    

Znn3bq.jpeg
查看: 446  |  回复: 0

liruihan

铁杆木虫 (正式写手)

[交流] Proton Pump Inhibitors but Not H2RAs Linked to Fracture Risk

May 10, 2011 — Proton pump inhibitor (PPI) use is linked to fracture risk, according to the results of a meta-analysis reported in the May/June issue of the Annals of Family Medicine.
"[PPIs] and histamine 2 receptor antagonists (H2RAs) are the most popular [acid-suppressive drugs] available, and millions of individuals currently take these medications on a continuous or long-term basis," write Chun-Sick Eom, MD, MPH, from Seoul National University Hospital, Republic of Korea, and colleagues. "These potent drugs are used to treat various disorders, and indications for long-term maintenance therapy with this drug class continue to expand. The relationship between [acid-suppressive drug] use and bone health remains unclear."

Using common keywords, the reviewers searched MEDLINE (PubMed), EMBASE, and the Cochrane Library databases from their beginnings through December 2010. Selection criteria were case-control, nested case-control, and cohort study designs. The articles were independently reviewed and selected by 2 investigators. Heterogeneity in the included articles necessitated use of random effects meta-analysis to arrive at pooled effect estimates.

The final analyses included 5 case-control studies, 3 nested case-control studies, and 3 cohort studies selected from 1809 articles meeting the initial inclusion criteria. With use vs nonuse of PPIs, the pooled odds ratio (OR) for fracture was 1.29 (95% confidence interval [CI], 1.18 - 1.41) compared with 1.10 (95% CI, 0.99 - 1.23) for use vs nonuse of H2RAs.

Risk for any fracture and for hip fracture was increased with long-term use of PPIs (adjusted OR, 1.30 [95% CI, 1.15 - 1.48]; adjusted OR, 1.34 [95% CI, 1.09 - 1.66], respectively). Vertebral fracture risk was also increased by 54% with PPI use. In contrast, long-term use of H2RA was not significantly associated with fracture risk.

"We found possible evidence linking PPI use to an increased risk of fracture, but no association between H2RA use and fracture risk," the study authors write. "Widespread use of PPIs with the potential risk of fracture is of great importance to public health. Clinicians should carefully consider their decision to prescribe PPIs for patients already having an elevated risk of fracture because of age or other factors."

Limitations of this study include possible uncontrolled confounding. The study authors therefore recommend further prospective studies including large randomized controlled trials with long follow-up.

"It is not necessary to treat patients to the point of an achlorhydric state to resolve acid reflux symptoms, so we recommend that drug doses be chosen thoughtfully with consideration of what is necessary to achieve desired therapeutic goals," the study authors conclude.

In an accompanying editorial, James M. Gill, MD, MPH, from Delaware Valley Outcomes Research in Wilmington, and colleagues discuss balancing risks and benefits of PPIs.

"PPIs have clear benefits in patients that require them, and they should not be denied to patients who are likely to benefit from them," the editorialists write. "On the other hand, long-term PPI exposure may lead to other unwanted effects and should be reserved for patients likely to benefit from them. They should not be used long-term for undifferentiated dyspepsia, but neither should they be denied for patients with established persistent [gastroesophageal reflux disease], [nonsteroidal anti-inflammatory drugs] risk, and hypersecretory states, while aiming for the lowest effective maintenance dose."

A National Research Foundation of Korea Grant funded by the Korean government supported this study. The study authors and editorialists have disclosed no relevant financial relationships.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 liruihan 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[文学芳草园] 献血感触 +6 呀呀好傻 2026-05-19 11/550 2026-05-19 22:26 by 而立得乐
[基金申请] 评审有感 +11 popular289 2026-05-18 17/850 2026-05-19 22:09 by 一碗砂锅米线
[有机交流] 反应很差,大量原料没有反应 5+3 Mr.Zot 2026-05-19 3/150 2026-05-19 13:56 by xtlilibin
[论文投稿] Sci. Bull. 悲剧经验 +4 jyang1999 2026-05-16 4/200 2026-05-19 10:56 by maolC
[考博] 26/27申博自荐-锂/钠电池方向 5+3 狗头军师. 2026-05-15 4/200 2026-05-19 09:10 by moonboat
[基金申请] 同样的基金本子,换个专家直接从C变A! +3 国自然国社科中 2026-05-19 3/150 2026-05-19 08:50 by Equinoxhua
[基金申请] 别被青基扩招骗了!26年科研内卷才刚刚开始 +3 国自然国社科中 2026-05-14 4/200 2026-05-19 08:48 by archvillain
[考博] 26/27博士推荐 +4 1木头人13949 2026-05-13 4/200 2026-05-19 08:29 by zhyzzh
[考博] 2026博士还有哪些学校有名额 +7 小王求读研 2026-05-15 8/400 2026-05-19 08:27 by zhyzzh
[基金申请] 面上本子正文33页,违规吗?会被低分嘛? +8 1234567wang 2026-05-17 10/500 2026-05-18 18:52 by zzahkj
[基金申请] 今年审到国自然15份,谈谈感受 +16 国自然国社科中 2026-05-17 16/800 2026-05-18 14:58 by gy116024
[硕博家园] 考博自荐 +5 科研狗111 2026-05-13 6/300 2026-05-18 11:22 by 糊糊涂涂好
[基金申请] 青C资助名额大幅增加! +12 西葫芦炒鸡蛋 2026-05-13 16/800 2026-05-18 10:02 by Equinoxhua
[基金申请] 重磅!青年科学基金项目(C类)资助增幅预计超过50% +7 水和泥不是水泥 2026-05-13 10/500 2026-05-18 07:50 by 水和泥不是水泥
[硕博家园] 我在等一个没有答案的答案 +3 Love_MH 2026-05-17 3/150 2026-05-18 02:22 by 竹林孤影
[考博] 光量子物理方向 博士招生 1人(2026.09) +3 sandyworld 2026-05-15 4/200 2026-05-17 14:38 by sandyworld
[有机交流] 求助2,4-二氯-5-嘧啶甲醛的合成方法 20+3 光吃不拉 2026-05-14 6/300 2026-05-16 19:46 by Equinoxhua
[有机交流] 求有机合成大神指点三硫酸乙烯酯(CAS:2793408-99-6)的合成路线 30+3 Leekmid 2026-05-13 10/500 2026-05-16 16:37 by czyzsu
[教师之家] 教学课件你会给同学吗 +8 硕士研究生吗 2026-05-13 8/400 2026-05-14 22:23 by 常规沥青
[考博] 材料类只有一篇综述能申博么 +4 乐逍遥谷 2026-05-13 4/200 2026-05-14 12:05 by zhyzzh
信息提示
请填处理意见